Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinopec Research Institute represents the collective R&D organizations of the China Petroleum & Chemical Corporation (Sinopec), including the Research Institute of Petroleum Processing (RIPP), the Beijing Research Institute of Chemical Industry (BRICI), and the Shanghai Research Institute of Petrochemical Technology (SRIPT). While primarily known for energy and petrochemicals, these institutes are major contributors to the life sciences and healthcare sectors through the development of medical-grade polymers, pharmaceutical intermediates, and bio-based chemicals. They provide essential raw materials for medical devices such as syringes, IV bags, and dialysis equipment, and are global leaders in the production of melt-blown fabrics for medical masks. The institutes are also advancing synthetic biology and enzymatic catalysis to create sustainable chemical processes and high-value pharmaceutical precursors. As a critical link in the global healthcare supply chain, Sinopec Research Institute supports both large-scale medical manufacturing and innovative biotechnological development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sinopec Research Institute.